StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

AstraZeneca's total debt was $29.49B at Jun 30, 2026. For fiscal 2025 it was $27.82B, down 3.6% from the year before. Over ten years it grew 6.3% a year on average. The highest annual figure on record is $29.79B in fiscal 2021.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$27.82B-3.6%
FY2024Dec 31, 2024$28.84B+4.9%
FY2023Dec 31, 2023$27.49B-2.8%
FY2022Dec 31, 2022$28.28B-5.1%
FY2021Dec 31, 2021$29.79B+51.2%
FY2020Dec 31, 2020$19.70B+12.2%
FY2019Dec 31, 2019$17.55B-8.2%
FY2018Dec 31, 2018$19.11B+7.3%
FY2017Dec 31, 2017$17.81B+5.9%
FY2016Dec 31, 2016$16.81B+11.7%
FY2015Dec 31, 2015$15.05B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$29.49B-8.7%
Q4 FY2025Dec 31, 2025$27.82B+1.2%
Q2 FY2025Jun 30, 2025$31.21B+8.0%
Q4 FY2024Dec 31, 2024$28.84B+2.0%
Q2 FY2024Jun 30, 2024$32.29B+12.8%
Q4 FY2023Dec 31, 2023$27.49B-7.7%
Q2 FY2023Jun 30, 2023$28.89B+7.8%
Q4 FY2022Dec 31, 2022$28.28B+43.6%
Q2 FY2022Jun 30, 2022$28.62B+49.8%
Q4 FY2021Dec 31, 2021$29.79B+69.7%
Q2 FY2021Jun 30, 2021$26.81B+41.2%
Q4 FY2020Dec 31, 2020$19.70B+3.1%
Q2 FY2020Jun 30, 2020$19.11B-2.8%
Q4 FY2019Dec 31, 2019$17.55B-1.4%
Q2 FY2019Jun 30, 2019$18.98B-3.8%
Q4 FY2018Dec 31, 2018$19.11B+13.7%
Q2 FY2018Jun 30, 2018$19.67B+30.7%
Q4 FY2017Dec 31, 2017$17.81B–
Q2 FY2017Jun 30, 2017$19.73B–
Q4 FY2016Dec 31, 2016$16.81B–
Q4 FY2015Dec 31, 2015$15.05B–

More AstraZeneca figures

See a number that looks wrong?